TZ Press, LLC Report issue

For profit Phase 1
Founded: Iowa City IA United States (2009)
Status: No NME R&D (2009)

Organization Overview

First Clinical Trial
2010
NCT01381354
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Multiple Sclerosis (Phase 1)

Multiple Sclerosis, Chronic Progressive (Phase 1)

Sclerosis (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 6